Equities
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)29.16
  • Today's Change-0.10 / -0.34%
  • Shares traded2.93m
  • 1 Year change+35.94%
  • Beta0.5910
Data delayed at least 15 minutes, as of Feb 13 2026 08:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Hengan International Group Co Ltd is an investment holding company primarily engaged in the manufacturing, distribution and sale of personal hygiene products. The Company mainly operates three segments. The Hygiene Products segment is engaged in production and sales of sanitary napkin, pantiliners, overnight pants and feminine intimate wash products under brands SPACE 7 and ANERLE, as well as disposable diaper products under brands ANERLE and ELDERJOY. The Tissue Paper Products segment is engaged in the production and sales of pocket handkerchiefs, box and soft tissue paper and kitchen towels or paper products under brands HEARTTEX and PINO. The Others segment is engaged in the production and sales of household products under brands H’YEAS and HOMELINE. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)25.64bn
  • Net income in HKD2.56bn
  • Incorporated--
  • Employees23.00k
  • Location
    Hengan International Group Co LtdHeng'an Industrial CityAnhai Town, Jinjiang CityQUANZHOU 362261ChinaCHN
  • Phone+86 59 585708888
  • Fax+86 5 957086666
  • Websitehttps://www.hengan.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Blue Moon Group Holdings Ltd8.46bn-520.90m17.06bn7.14k--2.19--2.01-0.0981-0.09811.591.330.85318.289.141,142,489.00-5.254.00-5.954.7960.4160.57-6.166.545.55--0.0108118.9716.823.95-330.34---5.31--
Emami Ltd3.29bn685.49m18.66bn3.22k26.91--21.975.6018.2018.2087.45--------11,866,520.00--22.86--30.8469.2365.9820.8120.43--54.49--50.896.467.4911.4621.63-22.4714.87
Kose Holdings Corp16.90bn773.39m18.76bn8.13k22.781.2112.771.11264.83264.835,785.644,979.350.85041.436.26--4.14--5.33--69.04--4.87--2.47--0.0338--2.30--101.25------
Softcare Ltd-100.00bn-100.00bn19.37bn--------------------------------------------------10.46--47.05------
Kobayashi Pharmaceutical Co Ltd8.48bn187.08m21.93bn3.62k111.961.9434.642.5949.1849.182,229.552,838.340.61313.453.27--1.355.691.697.1151.1154.432.218.932.10--0.0032--0.08581.95-63.68-28.2327.56--
Lion Corp21.60bn1.41bn24.15bn7.65k18.381.579.831.2199.6899.681,525.161,166.550.8234.255.37--6.055.098.887.7345.9445.997.366.041.47--0.080734.132.223.5030.15-1.58-6.425.46
Gillette India Ltd2.65bn535.50m24.39bn513.0044.92--39.559.06190.41190.41943.65--------59,941,520.00--------63.06--20.18----67.39----------------
Shanghai Chicmax Cosmetic Co Ltd8.38bn1.02bn25.66bn2.46k25.389.4521.613.102.572.5721.056.911.992.8321.364,016,794.0025.5114.1641.2827.5274.7768.5012.799.411.46320.910.107236.0562.0818.7769.4265.688.01--
Procter & Gamble Hygiene & Health Care3.75bn741.77m32.73bn421.0044.16--42.298.74264.78264.781,337.25--------103,105,200.00--------63.07--19.80----92.83----------------
Proya Cosmetics Co Ltd12.36bn1.79bn32.87bn3.39k18.275.09--2.653.993.9927.5714.311.362.7336.893,214,578.0020.1617.4926.5923.6972.8968.1114.8313.512.69--0.135530.1721.0428.1130.0031.6312.8531.64
Hengan International Group Co Ltd25.64bn2.56bn33.97bn23.00k12.961.409.111.322.252.2522.5220.890.51114.089.491,068,483.005.117.0910.0014.0931.8035.879.9913.320.989711.350.434766.07-4.620.1563-17.93-10.0711.56-8.42
Giant Biogene Holding Co Ltd6.92bn2.56bn36.41bn2.16k13.343.4513.595.182.512.516.799.710.6412.8818.453,937,032.0023.7426.1729.6647.5181.7583.6337.0443.514.65--0.000834.3257.1742.0842.0630.1516.52--
Unilever Indonesia Tbk PT14.85bn1.64bn40.79bn3.30k24.7919.5220.532.7592.79200.92838.70117.821.776.7317.959,682,771,000.0019.6224.7570.6778.0947.7648.7211.0712.290.568951.740.126--4.31-5.7621.78-13.164.50--
Colgate-Palmolive (India) Ltd5.09bn1.15bn50.21bn2.20k43.49--39.109.7848.8048.80217.04--------26,852,590.00--40.32--68.9469.7461.8822.4822.02--420.86--103.816.335.958.5511.973.4112.74
Data as of Feb 13 2026. Currency figures normalised to Hengan International Group Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

12.37%Per cent of shares held by top holders
HolderShares% Held
Lazard Asset Management LLCas of 21 Aug 202556.77m4.89%
The Vanguard Group, Inc.as of 07 Jan 202625.65m2.21%
Dimensional Fund Advisors LPas of 08 Jan 202612.76m1.10%
BlackRock Fund Advisorsas of 09 Jan 202610.54m0.91%
JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 20259.73m0.84%
Geode Capital Management LLCas of 04 Feb 20267.20m0.62%
Hang Seng Investment Management Ltd.as of 09 Jan 20265.96m0.51%
BlackRock Advisors (UK) Ltd.as of 09 Jan 20265.23m0.45%
American Century Investment Management, Inc.as of 08 Jan 20264.96m0.43%
Mellon Investments Corp.as of 09 Jan 20264.95m0.43%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.